Based on these data, we could hypothesize that escitalopram targets depression associated oxidative stress through GSH/GSSG redox cycle, therefore this could lead to normalisation of catalase in response to the reduced oxidative stress. The gene discussed is CAT; the disease is major depressive disorder.